Skip to main content
. 2010 Mar;21(3):428–437. doi: 10.1681/ASN.2009060672

Figure 5.

Figure 5.

GSK3β gene deletion reduced dDAVP-induced urine-concentrating capacity in mice. (a) WT and KO mice were injected with dDAVP (1 μM/kg body wt; intraperitoneally) and spot urine collected. *P < 0.001; n = 8. (b) Δ change in urine osmolality of dDAVP-treated mice compared with basal level. (c) pS256-AQP2 levels in the inner medulla and papilla of WT and KO mice 1 hour after dDAVP treatment. @P < 0.01.